CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		34,211,190
Beginning balance at Dec. 31, 2023	$ 196,988	$ 5	$ 441,641	$ (2)	$ (244,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(35,731)				(35,731)
Recognition of stock-based compensation expense	5,519		5,519
Issuance of common stock, net of issuance costs (in shares)		3,281,250
Issuance of common stock, net of issuance costs	98,329	$ 1	98,328
Issuance of pre-funded warrants, net of issuance costs	9,365		9,365
Exercise of vested stock options (in shares)		49,310
Exercise of vested stock options	802		802
Issuance of common stock upon the vesting of restricted stock units (in shares)		207,718
Other comprehensive income (loss)	(61)			(61)
Ending balance (in shares) at Mar. 31, 2024		37,749,468
Ending balance at Mar. 31, 2024	275,211	$ 6	555,655	(63)	(280,387)
Beginning balance (in shares) at Dec. 31, 2023		34,211,190
Beginning balance at Dec. 31, 2023	196,988	$ 5	441,641	(2)	(244,656)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(92,441)
Ending balance (in shares) at Sep. 30, 2024		38,196,072
Ending balance at Sep. 30, 2024	237,484	$ 6	574,229	346	(337,097)
Beginning balance (in shares) at Mar. 31, 2024		37,749,468
Beginning balance at Mar. 31, 2024	275,211	$ 6	555,655	(63)	(280,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(33,290)				(33,290)
Recognition of stock-based compensation expense	7,481		7,481
Issuance of common stock, net of issuance costs	3		3
Exercise of vested stock options (in shares)		99,678
Exercise of vested stock options	1,818		1,818
Issuance of common stock upon the vesting of restricted stock units (in shares)		115,251
Shares issued in connection with the employee stock purchase plan (in shares)		65,988
Shares issued in connection with the employee stock purchase plan	1,136		1,136
Other comprehensive income (loss)	(113)			(113)
Ending balance (in shares) at Jun. 30, 2024		38,030,385
Ending balance at Jun. 30, 2024	252,246	$ 6	566,093	(176)	(313,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(23,420)				(23,420)
Recognition of stock-based compensation expense	7,415		7,415
Exercise of vested stock options (in shares)		58,674
Exercise of vested stock options	721		721
Issuance of common stock upon the vesting of restricted stock units (in shares)		107,013
Other comprehensive income (loss)	522			522
Ending balance (in shares) at Sep. 30, 2024		38,196,072
Ending balance at Sep. 30, 2024	$ 237,484	$ 6	574,229	346	(337,097)
Beginning balance (in shares) at Dec. 31, 2024	38,349,826	38,349,826
Beginning balance at Dec. 31, 2024	$ 224,534	$ 6	584,559	179	(360,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(25,120)				(25,120)
Recognition of stock-based compensation expense	6,930		6,930
Issuance of common stock, net of issuance costs (in shares)		3,230,336
Issuance of common stock, net of issuance costs	134,771		134,771
Exercise of vested stock options (in shares)		78,436
Exercise of vested stock options	1,437		1,437
Issuance of common stock upon the vesting of restricted stock units (in shares)		336,939
Other comprehensive income (loss)	(94)			(94)
Ending balance (in shares) at Mar. 31, 2025		41,995,537
Ending balance at Mar. 31, 2025	$ 342,458	$ 6	727,697	85	(385,330)
Beginning balance (in shares) at Dec. 31, 2024	38,349,826	38,349,826
Beginning balance at Dec. 31, 2024	$ 224,534	$ 6	584,559	179	(360,210)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (58,045)
Exercise of vested stock options (in shares)	262,316
Ending balance (in shares) at Sep. 30, 2025	42,447,882	42,447,882
Ending balance at Sep. 30, 2025	$ 335,082	$ 6	753,042	289	(418,255)
Beginning balance (in shares) at Mar. 31, 2025		41,995,537
Beginning balance at Mar. 31, 2025	342,458	$ 6	727,697	85	(385,330)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(20,340)				(20,340)
Recognition of stock-based compensation expense	8,234		8,234
Exercise of vested stock options (in shares)		56,795
Exercise of vested stock options	1,205		1,205
Issuance of common stock upon the vesting of restricted stock units (in shares)		126,639
Shares issued in connection with the employee stock purchase plan (in shares)		32,001
Shares issued in connection with the employee stock purchase plan	1,101		1,101
Other comprehensive income (loss)	(46)			(46)
Ending balance (in shares) at Jun. 30, 2025		42,210,972
Ending balance at Jun. 30, 2025	332,612	$ 6	738,237	39	(405,670)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(12,585)				(12,585)
Recognition of stock-based compensation expense	12,243		12,243
Exercise of vested stock options (in shares)		127,085
Exercise of vested stock options	2,562		2,562
Issuance of common stock upon the vesting of restricted stock units (in shares)		109,825
Other comprehensive income (loss)	$ 250			250
Ending balance (in shares) at Sep. 30, 2025	42,447,882	42,447,882
Ending balance at Sep. 30, 2025	$ 335,082	$ 6	$ 753,042	$ 289	$ (418,255)